CHANCELLOR MICHAEL B enters LIPELLA PHARMACEUTICALS INC. with 709.78K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 12/20/2022ACC: 0001753926-22-001631
DirectorOfficer10% Owner· Chief Medical Officer
Since Dec 2022
709.78K
Baseline shares
100% direct
709.78K
Direct ownership
1 position
640K
Derivative underlying
5 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned709.78K
Total
709.78K direct709.78K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 709.78K | Direct |
| Total | 709.78K | 709.78K direct |
Derivative Holdings5
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
160K
Shares owned
N/A
Exercise price
5.00
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
5.00
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
1.25
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
80K
Shares owned
N/A
Exercise price
1.25
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
200K
Shares owned
N/A
Exercise price
1.25
Expiration
—
Exercise window
—
Total
Underlying
640K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock | 5.00 | — | — | 160K | N/A |
| Stock Options Direct | Common Stock | 5.00 | — | — | 100K | N/A |
| Stock Options Direct | Common Stock | 1.25 | — | — | 100K | N/A |
| Stock Options Direct | Common Stock | 1.25 | — | — | 80K | N/A |
| Stock Options Direct | Common Stock | 1.25 | — | — | 200K | N/A |
| Total | 640K | 0.00 | ||||